Work

Analysis of Human Immunodeficiency Virus Type 1 Drug Resistance in Children Receiving Nucleoside Analogue Reverse‐Transcriptase Inhibitors plus Nevirapine, Nelfinavir, or Ritonavir (Pediatric AIDS Clinical Trials Group 377)

Year: 2001

Type: article

Source: The Journal of Infectious Diseases

DOI: 10.1086/320728

Authors: Susan H. Eshleman, Paul Krogstad, J. Brooks Jackson, You‐Gan Wang, Sophia Lee, Lee‐Jen Wei, Shawn Cunningham, Michael Wantman, Andrew Wiznia, George Johnson, Sharon Nachman, Paul Palumbo

Institutions: Johns Hopkins University, Johns Hopkins Medicine, University of California, Los Angeles, Johns Hopkins Hospital, Harvard University, Albert Einstein College of Medicine, Jacobi Medical Center, Medical University of South Carolina, Stony Brook University, University of Medicine and Dentistry of New Jersey

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, University of California, Los Angeles, U.S. Public Health Service, National Institute of Allergy and Infectious Diseases

Awards: G2886203562, G4315264890, G4809071377, INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC), New Jersey Pediatric AIDS Clinical Trials Consortium

OpenAlex ID: W2144440979

FWCI: 4.855

Cites: 26

Cited by: 44

Related to: 10